chrX-153592536-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_152274.5(CCNQ):c.627C>T(p.Ala209=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,211,231 control chromosomes in the GnomAD database, including 17 homozygotes. There are 1,171 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., 57 hem., cov: 25)
Exomes 𝑓: 0.0021 ( 16 hom. 1114 hem. )
Consequence
CCNQ
NM_152274.5 synonymous
NM_152274.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.442
Genes affected
CCNQ (HGNC:28434): (cyclin Q) Mutations in this gene have been shown to cause an X-linked dominant STAR syndrome that typically manifests syndactyly, telecanthus and anogenital and renal malformations. The protein encoded by this gene contains a cyclin-box-fold domain which suggests it may have a role in controlling nuclear cell division cycles. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-153592536-G-A is Benign according to our data. Variant chrX-153592536-G-A is described in ClinVar as [Benign]. Clinvar id is 702552.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153592536-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.442 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0012 (136/113391) while in subpopulation SAS AF= 0.0243 (68/2797). AF 95% confidence interval is 0.0197. There are 1 homozygotes in gnomad4. There are 57 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 57 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCNQ | NM_152274.5 | c.627C>T | p.Ala209= | synonymous_variant | 4/5 | ENST00000576892.8 | |
CCNQ | NM_001130997.3 | c.627C>T | p.Ala209= | synonymous_variant | 4/5 | ||
CCNQ | XM_011531214.3 | c.501C>T | p.Ala167= | synonymous_variant | 4/5 | ||
CCNQ | XM_047442631.1 | c.429+2011C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCNQ | ENST00000576892.8 | c.627C>T | p.Ala209= | synonymous_variant | 4/5 | 1 | NM_152274.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00120 AC: 136AN: 113337Hom.: 1 Cov.: 25 AF XY: 0.00161 AC XY: 57AN XY: 35473
GnomAD3 genomes
AF:
AC:
136
AN:
113337
Hom.:
Cov.:
25
AF XY:
AC XY:
57
AN XY:
35473
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00321 AC: 580AN: 180830Hom.: 3 AF XY: 0.00535 AC XY: 355AN XY: 66346
GnomAD3 exomes
AF:
AC:
580
AN:
180830
Hom.:
AF XY:
AC XY:
355
AN XY:
66346
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00205 AC: 2255AN: 1097840Hom.: 16 Cov.: 31 AF XY: 0.00307 AC XY: 1114AN XY: 363286
GnomAD4 exome
AF:
AC:
2255
AN:
1097840
Hom.:
Cov.:
31
AF XY:
AC XY:
1114
AN XY:
363286
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00120 AC: 136AN: 113391Hom.: 1 Cov.: 25 AF XY: 0.00160 AC XY: 57AN XY: 35537
GnomAD4 genome
AF:
AC:
136
AN:
113391
Hom.:
Cov.:
25
AF XY:
AC XY:
57
AN XY:
35537
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 06, 2023 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at